NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Cardiovascular Business Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cardiovascular Business Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Burnham Institute, La Jolla



Plasma fibronectin guides angiostatic peptides to angiogenic vessels



April 26th, 2005

Plasma fibronectin guides angiostatic peptides to angiogenic vessels.

"A group of angiogenesis inhibitors are derived from fragments of extracellular matrix or blood proteins. Endostatin, antithrombin, and anastellin are members of this group of substances. The plasma adhesion proteins fibronectin and vitronectin serve as cofactors for these three antiangiogenic proteins," scientists writing in the journal Proceedings of the National Academy of Sciences of the United States of America report.

"Anginex is a synthetic 33-amino acid peptide that was originally modeled to reproduce the beta-sheet structure of antiangiogenic proteins. Here, we show...


Source: Cardiovascular Business Week (2005-04-26)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login